103 related articles for article (PubMed ID: 1841411)
1. [Preliminary results of the treatment of patients with chronic active hepatitis (CAH) HBsAg+,HBeAg+ with low oral doses of human interferon-alpha].
Zielińska W; Paszkiewicz J; Korczak A; Własiuk M; Zółtowska A; Szutowicz J; Cummins J; Georgiades J
Przegl Epidemiol; 1991; 45(4):325-30. PubMed ID: 1841411
[TBL] [Abstract][Full Text] [Related]
2. Treatment of fourteen chronic active HBsAg+, HBeAg+ hepatitis patients with low dose natural human interferon alpha administered orally.
Zielińska W; Paszkiewicz J; Korczak A; Własiuk M; Zółtowska A; Szutowicz A; Cummins JM; Georgiades JA
Arch Immunol Ther Exp (Warsz); 1993; 41(3-4):241-51. PubMed ID: 8129568
[TBL] [Abstract][Full Text] [Related]
3. Phase II clinical trial of combined natural interferon-beta plus recombinant interferon-gamma treatment of chronic hepatitis B.
Musch E; Högemann B; Gerritzen A; Fischer HP; Wiese M; Kruis W; Malek M; Gugler R; Schmidt G; Huchzermeyer H; Gerlach U; Dengler HJ; Sauerbruch T
Hepatogastroenterology; 1998; 45(24):2282-94. PubMed ID: 9951911
[TBL] [Abstract][Full Text] [Related]
4. Transient increase of HBsAg levels following human IFN alpha treatment signalises the patient's response in chronic active hepatitis B.
Stancek D; Hajnická V; Blaskovicová H; Sudová J; Laktis K; Janota S; Jezek P
Acta Virol; 1990 Sep; 34(5):457-66. PubMed ID: 1981456
[TBL] [Abstract][Full Text] [Related]
5. [Treatment of hepatitis B surface antigen (HBsAg)-positive chronic hepatitis with recombinant alpha-A-interferon. Results of a phase II study].
Hess G; Weber C; Rossol S; Voth R; Drees N; Meyer zum Büschenfelde KH
Z Gastroenterol; 1988 Jul; 26(7):380-7. PubMed ID: 3223006
[TBL] [Abstract][Full Text] [Related]
6. Comparison of the long-term effects of treatment with oral and parenteral interferon alpha in chronic viral hepatitis patients.
Zielińska W; Korczak-Rogoń A; Paszkiewicz J; Kowalik M; Cummins JM; Georgiades JA
Arch Immunol Ther Exp (Warsz); 1996; 44(5-6):359-66. PubMed ID: 9017152
[TBL] [Abstract][Full Text] [Related]
7. Treatment of chronic hepatitis B (HBeAg-HBV DNA-positive) with lymphoblastoid alpha interferon with or without corticosteroids: short- and long-term follow-up.
Zavaglia C; Bottelli R; Bellati G; Asti L; Mondazzi L; Iamoni G; Zanetti A; Tanzi E; Fesce E; Gelosa F; Maggi G; Ideo G
Ital J Gastroenterol; 1996; 28(6):324-31. PubMed ID: 8891847
[TBL] [Abstract][Full Text] [Related]
8. Treatment of chronic viral hepatitis type B with oral mucosal administration of natural human interferon alpha lozenges.
Caban J; Mossor-Ostrowska J; Zyrkowska-Bieda T; Zejc M; Janas-Skulina U; Cieśla A; Cummins JM; Georgiades JA
Arch Immunol Ther Exp (Warsz); 1993; 41(3-4):229-35. PubMed ID: 8129566
[TBL] [Abstract][Full Text] [Related]
9. [Morphologic findings in liver tissue in chronic active hepatitis B after seroconversion from HBeAg to anti-HBe].
Chlumská A; Stránský J; Taimr P; Baumruk L; Nevaril M
Vnitr Lek; 1995 Jul; 41(7):445-8. PubMed ID: 7571477
[TBL] [Abstract][Full Text] [Related]
10. [Alpha-interferon antiviral treatment in 100 patients with chronic hepatitis B].
Janssen HL; Berk L; de Man RA; Heijtink RA; Schalm SW
Ned Tijdschr Geneeskd; 1992 Apr; 136(17):835-9. PubMed ID: 1522928
[TBL] [Abstract][Full Text] [Related]
11. Treatment of chronic hepatitis B with human lymphoblastoid interferon: results of a controlled trial.
Mazzella G; Villanova N; Abdu-Ahmed M; Barbara L; Saracco G; Rizzetto M; Cancellieri C; Roda E
Chemioterapia; 1988 Dec; 7 Suppl 3():12-4. PubMed ID: 3073868
[TBL] [Abstract][Full Text] [Related]
12. [A controlled study of treatment with recombinant interferon alpha of chronic hepatitis due to the B virus in childhood].
Carreño V; Porres JC; Ruiz-Moreno M; Gutiez J; Bartolomé FJ
Rev Esp Enferm Dig; 1991 Jan; 79(1):24-8. PubMed ID: 2031770
[TBL] [Abstract][Full Text] [Related]
13. Immunotherapy of chronic active viral hepatitis B with propionibacterium granulosum.
Gil J; Ziemka J; Brzosko WJ; Dabrowski M; Dabrowska-Bernstein B; Szmigielski S; Ko HL; Jeljaszewicz J; Pulverer G
Hepatogastroenterology; 1984 Jun; 31(3):109-18. PubMed ID: 6205967
[TBL] [Abstract][Full Text] [Related]
14. Results of interferon treatment in children with chronic hepatitis B.
Grigorescu-Sido P; Călin L; Manasia R; Mireştean S; Creţ V; Skorka C; Grigorescu-Sido A
Rom J Gastroenterol; 2002 Dec; 11(4):285-90. PubMed ID: 12532198
[TBL] [Abstract][Full Text] [Related]
15. [Evaluation of clinical effectiveness of colchicine in the treatment of chronic active hepatitis with transformation to liver cirrhosis].
Simon K; Gładysz A; Zalewska M; Machaj A
Przegl Epidemiol; 1991; 45(4):331-4. PubMed ID: 1841412
[TBL] [Abstract][Full Text] [Related]
16. [Effect of interferon on hepatitis B virus infection in patients with chronic active hepatitis].
Hinoue Y; Unoura M; Kato Y; Kobayashi K; Hattori N
Gan To Kagaku Ryoho; 1984 Feb; 11(2):205-11. PubMed ID: 6696458
[TBL] [Abstract][Full Text] [Related]
17. Natural human interferon alpha given orally has different effects on patients with distinct forms of chronic viral hepatitis B.
Georgiades JA; Caban J; Zyrkowska-Bieda T; Zejc M; Jonas-Skulina U; Cieśla A
Arch Immunol Ther Exp (Warsz); 1996; 44(2-3):187-94. PubMed ID: 8915525
[TBL] [Abstract][Full Text] [Related]
18. Interferon-alpha and zidovudine combination therapy for chronic hepatitis B: results of a randomized, placebo-controlled trial.
Janssen HL; Berk L; Heijtink RA; ten Kate FJ; Schalm SW
Hepatology; 1993 Mar; 17(3):383-8. PubMed ID: 8444411
[TBL] [Abstract][Full Text] [Related]
19. Interferon in chronic active hepatitis B. Preliminary results.
Waked I; Amin M; Abd-el Fattah SA; Osman L; Sabbour M
Chemioterapia; 1988 Jun; 7(3):198-202. PubMed ID: 3168077
[TBL] [Abstract][Full Text] [Related]
20. Intramuscular natural beta interferon in the treatment of chronic hepatitis B: a multicentre trial. Italian Hepatitis B Study Group.
Capalbo M; Palmisano L; Bonino F; Pellas C; Maset J
Ital J Gastroenterol; 1994 Jun; 26(5):238-41. PubMed ID: 7919465
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]